111, Inc. American Depositary Shares (YI) — Analysis Summary
111, Inc. American Depositary Shares (YI) has a market cap of $30.44M with year-over-year revenue growth of -12.5%. Net margin stands at -0.2%. The stock trades at a P/E ratio of -9.7.
Key Takeaways
- Revenue changed -12.5% year-over-year
- Net margin of -0.2%
- P/E ratio of -9.7
Compared with its sector, YI posted revenue growth of -12.5% and trades at a P/E of -9.7.
111, Inc. American Depositary Shares (YI)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Debt/EBITDA at 20.3x — highly leveraged, potential refinancing risk
Interest coverage at -0.1x — earnings do not cover interest payments
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.
Employees
1,063
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.